Table 2.
Estimate | P value | |
HIV positive vs. HIV negative | − 0.13 | 0.01 |
Age | 0.04 | 0.31 |
Female vs. male | 0.0001 | 0.97 |
Non-white vs. white | − 0.09 | 0.001 |
BMI | 0.17 | 0.01 |
Current smoker (yes vs. no) | 0.07 | 0.03 |
ARV duration | − 0.0001 | 0.63 |
HIV duration | 0.0002 | 0.54 |
Family history of MI (yes vs. no) | 0.07 | 0.03 |
Current CD4+ cell count | − 0.02 | 0.31 |
Nadir CD4+ cell count | 0.01 | 0.82 |
Current NRTI | 0.06 | 0.31 |
Current NNRTI | 0.02 | 0.69 |
Current PI | − 0.08 | 0.04 |
IL-6 | 0.02 | 0.24 |
VCAM | 0.1 | 0.01 |
hs-CRP | 0.02 | 0.08 |
D dimer | 0.02 | 0.23 |
IFAB | − 0.04 | 0.09 |
LBP | − 0.01 | 0.72 |
sCD14 | 0.02 | 0.71 |
sCD163 | 0.05 | 0.06 |
Bold font indicates statistical significance (P < 0.05). ARV, antiretroviral; BMI, body mass index; hs-CRP, high-sensitivity C-reactive protein; IFAB, intestinal fatty acid binding protein; IL-6, interleukin 6; IQR, interquartile range; LBP, lipopolysaccharide-binding protein; MI, myocardial infarction; NNRTI, non-nucleoside reverse transcriptase inhibitors; NRTI, nucleoside reverse transcriptase inhibitors; PI, protease inhibitor.